Treatment of Deafferentation Pain by Chronic Stimulation of the Motor Cortex: Report of a Series of 20 Cases

Nguyen, Jean Paul; Kéravel, Y.; Fève, A.; Uchiyama, Takuya; Césaro, P.; Guérinel, C. Le; Pollin, B.

doi:10.1007/978-3-7091-6513-3_10

Cited by 87 publications

(109 citation statements)

References 8 publications

Supporting

Mentioning

104

Contrasting

Unclassified

Order By: Relevance

“…Hardware failures and infection were the second and third most likely complications, respectively. Both Myerson et al 29 and Nguyen et al 66 reported hematomas, one of which was asymptomatic and the other required surgical intervention.…”

Section: Introductionmentioning

confidence: 99%

Motor Cortex Stimulation for Pain and Movement Disorders

Arle

Shils

2008

Neurotherapeutics

View full text Add to dashboard Cite

Summary:Since initial reports in the early 1990s, stimulation of the M1 region of the cortex (MCS) has been used to treat chronic refractory pain conditions and a variety of movement disorders. A Medline search of literature between 1991 and 2007 revealed 512 cases using MCS. Although most of these relate to the treatment of pain (422), 84 of them involve movement disorders. More recently, several studies have specifically looked at treating Parkinson's disease (PD) with MCS. We report here several of our own cases using MCS to treat poststroke and non-poststroke pain syndromes and movement disorders (n ϭ 8), PD (n ϭ 4), ET (n ϭ 2), and cortico-basal degeneration (n ϭ 1). We also cover the essential history of this procedure and our current research using computational modeling to understand further the underlying mechanisms of MCS.

show abstract

Section: Introductionmentioning

confidence: 99%

Motor Cortex Stimulation for Pain and Movement Disorders

Arle

Shils

2008

Neurotherapeutics

View full text Add to dashboard Cite

show abstract

“…Motor cortex stimulation has been clinically tested in patients with trigeminal neuralgia and central pain from stroke 62,99,111,149 with mixed results. A meta-analysis of motor cortex stimulation to reduce pain showed efficacy in approximately 50% of patients (with 40%-50% improvement).…”

Section: Human Trials Of Direct Cortical and Spinal Cord Stimulationmentioning

confidence: 99%

Neurostimulation for traumatic brain injury

Shin

Dixon²,

Okonkwo³

et al. 2014

JNS

View full text Add to dashboard Cite

Traumatic brain injury (TBI) remains a significant public health problem and is a leading cause of death and disability in many countries. Durable treatments for neurological function deficits following TBI have been elusive, as there are currently no FDA-approved therapeutic modalities for mitigating the consequences of TBI. Neurostimulation strategies using various forms of electrical stimulation have recently been applied to treat functional deficits in animal models and clinical stroke trials. The results from these studies suggest that neurostimulation may augment improvements in both motor and cognitive deficits after brain injury. Several studies have taken this approach in animal models of TBI, showing both behavioral enhancement and biological evidence of recovery. There have been only a few studies using deep brain stimulation (DBS) in human TBI patients, and future studies are warranted to validate the feasibility of this technique in the clinical treatment of TBI. In this review, the authors summarize insights from studies employing neurostimulation techniques in the setting of brain injury. Moreover, they relate these findings to the future prospect of using DBS to ameliorate motor and cognitive deficits following TBI.

show abstract

“…8,15,20) Excellent results have also been reported in the treatment of trigeminal neuropathic pain, with 75-100% of patients achieving pain relief. 6,13,14,18) A prospective study used MCS to treat 10 patients with neuropathic facial pain attributed to surgical trigeminal root injury, poststroke, postherpetic, or no cause. 3) Immediate pain relief was achieved in 88% of patients, with 75% pain relief at a mean follow-up period of 10 months.…”

Section: Tnmentioning

confidence: 99%

Motor Cortex Stimulation for Intractable Neuropathic Facial Pain Related to Multiple Sclerosis -Case Report-

Tanei

Kajita

Wakabayashi

2010

Neurol. Med. Chir.(Tokyo)

View full text Add to dashboard Cite

A 33-year-old man presented with ongoing severe right facial pain and sensory disturbances caused by multiple sclerosis (MS). Neuroimaging demonstrated demyelinating lesions in the right dorsal pons and medulla oblongata. The pain was refractory to carbamazepine at 800 mg/day, gabapentin at 1800 mg/day, morphine at 30 mg/day, amitriptyline at 60 mg/day, and diazepam at 4 mg/day, along with twice-monthly ketamine (60 mg) drip infusions. The patient underwent motor cortex stimulation (MCS), resulting in À60% pain relief, reduction in the required doses of pain medications, and discontinuation of ketamine administration. MCS is effective for MS-related neuropathic facial pain.

show abstract

Treatment of Deafferentation Pain by Chronic Stimulation of the Motor Cortex: Report of a Series of 20 Cases

Cited by 87 publications

References 8 publications

Motor Cortex Stimulation for Pain and Movement Disorders

Motor Cortex Stimulation for Pain and Movement Disorders

Neurostimulation for traumatic brain injury

Motor Cortex Stimulation for Intractable Neuropathic Facial Pain Related to Multiple Sclerosis -Case Report-

Contact Info

Product

Resources

About